Literature DB >> 28516211

Early endothelialization associated with a biolimus A9 bioresorbable polymer stent in a porcine coronary model.

Masayuki Mori1, Kenji Sakata1, Chiaki Nakanishi1, Takuya Nakahashi1, Masa-Aki Kawashiri1, Kazuaki Yoshioka2, Yoh Takuwa2, Hirofumi Okada1, Jun-Ichiro Yokawa1, Masaya Shimojima1, Tsuyoshi Yoshimuta1, Shohei Yoshida1, Masakazu Yamagishi3, Kenshi Hayashi1.   

Abstract

Although Nobori®, with a bioresorbable polymer and biolimus A9 abluminal coating, has unique characteristics, few data exist regarding endothelialization early after implantation. Fifteen Nobori® and 14 control bare-metal stents (S-stent™) were implanted in 12 pigs. Histopathology of stented segments, inflammation, and intimal fibrin content was evaluated on the 2nd and 14th day after implantation. On the 2nd day, endothelial cells were morphologically and immunohistologically confirmed on the surface of both stents, although some inflammatory cells might be involved. Stent surface endothelialization evaluated with a scanning electron microscope showed partial cellular coverage in both stents. On the 14th day, neointimal thickness and percentage of the neointimal area were significantly lower in Nobori® than in S-stent™ (51.4 ± 4.5 vs. 76.4 ± 23.6 µm, p < 0.05 and 10.8 ± 2.6 vs. 14.1 ± 4.2%, p < 0.01). No significant differences were found in these parameters on the 2nd day (17.3 ± 14.9 vs. 26.7 ± 13.6 µm and 3.7 ± 3.0 vs. 6.7 ± 3.7%), in inflammatory and intimal fibrin content scores. These results demonstrate that endothelialization could occur early after Nobori® implantation with similar inflammatory reaction to bare-metal stents, probably contributing to low frequency of in-stent thrombosis and restenosis.

Entities:  

Keywords:  Bioresorbable polymer; Drug-eluting stent; Endothelialization

Mesh:

Substances:

Year:  2017        PMID: 28516211     DOI: 10.1007/s00380-017-0992-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  33 in total

Review 1.  Coronary-artery stents.

Authors:  Patrick W Serruys; Michael J B Kutryk; Andrew T L Ong
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

2.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

3.  Comparison of first- and second-generation drug-eluting stent efficacies for treating left main and/or three-vessel disease: a propensity matched study.

Authors:  Norihiro Kobayashi; Yoshiaki Ito; Keisuke Hirano; Masahiro Yamawaki; Motoharu Araki; Tsuyoshi Sakai; Hideyuki Takimura; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutsumi; Takuro Takama; Hiroya Takafuji; Takashi Maruyama; Yohsuke Honda; Takahiro Tokuda; Kenji Makino; Shigemitsu Shirai; Toshiya Muramatsu
Journal:  Heart Vessels       Date:  2016-03-02       Impact factor: 2.037

4.  Association of Adventitial Vasa Vasorum and Inflammation With Coronary Hyperconstriction After Drug-Eluting Stent Implantation in Pigs In Vivo.

Authors:  Kensuke Nishimiya; Yasuharu Matsumoto; Tomohiko Shindo; Kenichiro Hanawa; Yuhi Hasebe; Ryuji Tsuburaya; Takashi Shiroto; Jun Takahashi; Kenta Ito; Hatsue Ishibashi-Ueda; Satoshi Yasuda; Hiroaki Shimokawa
Journal:  Circ J       Date:  2015-06-01       Impact factor: 2.993

5.  Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Authors:  Jonathan R Nebeker; Renu Virmani; Charles L Bennett; Jennifer M Hoffman; Matthew H Samore; Jorge Alvarez; Charles J Davidson; June M McKoy; Dennis W Raisch; Brian K Whisenant; Paul R Yarnold; Steven M Belknap; Dennis P West; Jonathan E Gage; Richard E Morse; Gordana Gligoric; Laura Davidson; Marc D Feldman
Journal:  J Am Coll Cardiol       Date:  2005-12-01       Impact factor: 24.094

6.  Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.

Authors:  Stéphane Cook; Elena Ladich; Gaku Nakazawa; Parham Eshtehardi; Michel Neidhart; Rolf Vogel; Mario Togni; Peter Wenaweser; Michael Billinger; Christian Seiler; Steffen Gay; Bernhard Meier; Werner J Pichler; Peter Jüni; Renu Virmani; Stephan Windecker
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

7.  Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model.

Authors:  R S Schwartz; K C Huber; J G Murphy; W D Edwards; A R Camrud; R E Vlietstra; D R Holmes
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

Review 8.  Endothelial cell function and thrombosis.

Authors:  J D Pearson
Journal:  Baillieres Clin Haematol       Date:  1994-09

9.  Repeated occurrence of slow flow phenomenon during and late after sirolimus-eluting stent implantation.

Authors:  Kenji Sakata; Masanobu Namura; Toshimitsu Takagi; Naoto Tama; Isao Inoki; Hidenobu Terai; Yuki Horita; Masatoshi Ikeda; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2014-01-30       Impact factor: 2.037

10.  Vascular responses to a biodegradable polymer (polylactic acid) based biolimus A9-eluting stent in porcine models.

Authors:  Hitomi Hagiwara; Yoshiaki Hiraishi; Hisako Terao; Toshiyuki Hirai; Atsushi Sakaoka; Masashige Sasaki; Satomi Murota; Katsumi Inoue; Junji Kimura
Journal:  EuroIntervention       Date:  2012-10       Impact factor: 6.534

View more
  5 in total

1.  Very late bare metal stent thrombosis in the setting of discontinuation of optimal medical therapy for 2 years.

Authors:  Kota Murai; Kenji Sakata; Tomohito Mabuchi; Masato Yamaguchi; Masayuki Mori; Kenshi Hayashi; Masa-Aki Kawashiri
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

Review 2.  Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?

Authors:  Allen J Weiss; Marta Lorente-Ros; Ashish Correa; Nitin Barman; Jacqueline E Tamis-Holland
Journal:  Curr Atheroscler Rep       Date:  2022-07-11       Impact factor: 5.967

3.  Osstem Cardiotec Centum Stent Versus Xience Alpine Stent for De Novo Coronary Artery Lesion: A Multicenter, Randomized, Parallel-Designed, Single Blind Test.

Authors:  Chang-Hwan Yoon; Jihong Jang; Seung Ho Hur; Jun-Hee Lee; Seung Hwan Han; Soon-Jun Hong; Kiyuk Chang; In-Ho Chae
Journal:  Korean Circ J       Date:  2022-01-03       Impact factor: 3.101

4.  Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model.

Authors:  Daisuke Kitano; Suguru Migita; Yuxin Li; Rie Takahashi; Yoshiki Taniguchi; Takafumi Kurosawa; Mitsumasa Sudo; Hironori Haruta; Takafumi Hiro; Tadateru Takayama; Masako Mitsumata; Taro Matsumoto; Yasuo Okumura; Atsushi Hirayama
Journal:  J Atheroscler Thromb       Date:  2020-11-18       Impact factor: 4.928

5.  Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model.

Authors:  Masayuki Mori; Kenji Sakata; Junichiro Yokawa; Chiaki Nakanishi; Kota Murai; Hirofumi Okada; Masaya Shimojima; Shohei Yoshida; Kazuaki Yoshioka; Yoh Takuwa; Kenshi Hayashi; Masakazu Yamagishi; Masa-Aki Kawashiri
Journal:  J Interv Cardiol       Date:  2020-04-27       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.